Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/05/341   
Active ingredient: Imexon
Indication: Treatment of ovarian cancer
Sponsor: ICON Clinical Research (U.K.) Limited
2 Globeside, Globeside Business Park, Marlow, Buckinghamshire SL7 1HZ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
3/01/2006 Orphan designation EMEA/OD/065/05 (2005)6002 of 23/12/2005